News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
646,445 Results
Type
Article (61342)
Company Profile (72)
Press Release (585031)
Multimedia
Podcasts (62)
Webinars (13)
Section
Business (173732)
Career Advice (2730)
Deals (32437)
Drug Delivery (97)
Drug Development (76877)
Employer Resources (150)
FDA (14941)
Job Trends (13893)
News (304954)
Policy (28952)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (90)
Alliances (43180)
ALS (95)
Alzheimer's disease (1334)
Antibody-drug conjugate (ADC) (117)
Approvals (14951)
Artificial intelligence (277)
Autoimmune disease (24)
Automation (16)
Bankruptcy (290)
Best Places to Work (10857)
BIOSECURE Act (16)
Biosimilars (102)
Biotechnology (54)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (288)
Cancer (2256)
Cardiovascular disease (173)
Career advice (2313)
Career pathing (33)
CAR-T (163)
Cell therapy (449)
Cervical cancer (21)
Clinical research (62640)
Collaboration (820)
Company closure (2)
Compensation (356)
Complete response letters (20)
COVID-19 (2572)
CRISPR (45)
C-suite (273)
Cystic fibrosis (103)
Data (2304)
Decentralized trials (2)
Denatured (26)
Depression (44)
Diabetes (260)
Diagnostics (6173)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (115)
Drug pricing (105)
Drug shortages (23)
Duchenne muscular dystrophy (92)
Earnings (60656)
Editorial (41)
Employer branding (18)
Employer resources (132)
Events (94761)
Executive appointments (785)
FDA (16325)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (777)
Gene editing (114)
Generative AI (21)
Gene therapy (322)
GLP-1 (678)
Government (4477)
Grass and pollen (6)
Guidances (165)
Healthcare (18230)
Huntington's disease (20)
IgA nephropathy (26)
Immunology and inflammation (116)
Indications (28)
Infectious disease (2709)
Inflammatory bowel disease (142)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (99)
Interviews (527)
IPO (14816)
IRA (38)
Job creations (3417)
Job search strategy (1941)
Kidney cancer (10)
Labor market (34)
Layoffs (515)
Leadership (22)
Legal (6437)
Liver cancer (70)
Lung cancer (311)
Lymphoma (150)
Machine learning (9)
Management (53)
Manufacturing (301)
MASH (74)
Medical device (12664)
Medtech (12669)
Mergers & acquisitions (18239)
Metabolic disorders (662)
Multiple sclerosis (80)
NASH (13)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1880)
NextGen: Class of 2025 (6375)
Non-profit (4318)
Now hiring (13)
Obesity (331)
Opinion (233)
Ovarian cancer (77)
Pain (96)
Pancreatic cancer (84)
Parkinson's disease (146)
Partnered (22)
Patents (247)
Patient recruitment (116)
Peanut (50)
People (59620)
Pharmaceutical (20)
Pharmacy benefit managers (17)
Phase I (19716)
Phase II (27651)
Phase III (20169)
Pipeline (1367)
Policy (135)
Postmarket research (2473)
Preclinical (8423)
Press Release (67)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (250)
Rare diseases (371)
Real estate (5990)
Recruiting (61)
Regulatory (20152)
Reports (35)
Research institute (2397)
Resumes & cover letters (405)
Rett syndrome (6)
RNA editing (3)
RSV (35)
Schizophrenia (71)
Series A (134)
Series B (92)
Service/supplier (9)
Sickle cell disease (52)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3350)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (34)
The Weekly (34)
Vaccines (674)
Venture capitalists (35)
Weight loss (204)
Women's health (31)
Worklife (19)
Date
Today (233)
Last 7 days (921)
Last 30 days (3195)
Last 365 days (30316)
2025 (11610)
2024 (32306)
2023 (36369)
2022 (46632)
2021 (51571)
2020 (50722)
2019 (44791)
2018 (34074)
2017 (30749)
2016 (30093)
2015 (35467)
2014 (28404)
2013 (24996)
2012 (26252)
2011 (26486)
2010 (24954)
Location
Africa (871)
Alabama (55)
Alaska (6)
Arizona (172)
Arkansas (14)
Asia (38124)
Australia (6859)
California (5920)
Canada (1911)
China (503)
Colorado (259)
Connecticut (268)
Delaware (151)
Europe (89190)
Florida (907)
Georgia (211)
Idaho (56)
Illinois (566)
India (25)
Indiana (290)
Iowa (10)
Japan (167)
Kansas (97)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (860)
Massachusetts (4262)
Michigan (230)
Minnesota (355)
Mississippi (2)
Missouri (88)
Montana (29)
Nebraska (23)
Nevada (62)
New Hampshire (61)
New Jersey (1720)
New Mexico (29)
New York (1712)
North Carolina (985)
North Dakota (9)
Northern California (2599)
Ohio (201)
Oklahoma (15)
Oregon (36)
Pennsylvania (1292)
Puerto Rico (13)
Rhode Island (31)
South America (1178)
South Carolina (21)
South Dakota (1)
Southern California (2256)
Tennessee (101)
Texas (899)
United States (22376)
Utah (180)
Virginia (150)
Washington D.C. (52)
Washington State (530)
West Virginia (3)
Wisconsin (64)
646,445 Results for "university of amsterdam".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
Femasys, Inc. announces it will be participating at the European Society of Human Reproduction and Embryology’s (ESHRE) 40th Annual Meeting in Amsterdam on July 7-10.
June 27, 2024
·
4 min read
Biotech Beach
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
Renovaro Inc. and the Amsterdam UMC Cancer Center announced an intended partnership and therefore signed an MoU to establish a joint company based in the Netherlands aimed at pioneering the next generation of personalized cancer immunotherapy.
May 24, 2024
·
5 min read
Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office
Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced that it is one of the leading patent applicants at the European Patent Office.
March 19, 2024
·
2 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Business
Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)
Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced the proposal to appoint Charlotte Hanneman as member of the Board of Management, fulfilling the role of Chief Financial Officer, effective October 1, 2024.
February 28, 2024
·
5 min read
Biotech Beach
Healis selected to present at key biotechnology and neuroscience investor conferences in Amsterdam, New York, and San Diego
Healis Therapeutics is pleased to announce it has been competitively selected to present at several key investor conferences.
February 12, 2024
·
1 min read
Drug Development
Alzheon to Present Baseline Imaging Characteristics from Ongoing APOLLOE4 Phase 3 Trial of Oral Tablet ALZ-801 (Valiltramiprosate) and Positive Biomarker/Clinical Correlations from Phase 2 Biomarker Study at AAIC in Amsterdam
Alzheon, Inc. announced that it will be presenting baseline imaging characteristics from its ongoing APOLLOE4 Phase 3 clinical trial and new correlation analyses from the Phase 2 biomarker study evaluating ALZ-801 oral tablet at the upcoming Alzheimer’s Association International Conference, to be held from July 16 – 20, 2023 in Amsterdam, Netherlands.
July 11, 2023
·
11 min read
Business
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
ProQR Therapeutics NV. announced the Annual General Meeting of Shareholders will take place on Wednesday, May 22, 2024 at 1630 CET at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands.
April 23, 2024
·
7 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Affimed Announces Annual General Meeting of Shareholders - May 28, 2024
Affimed N.V. announced that its 2024 Annual General Meeting of Shareholders will be held on June 26, 2024 at 09:00 a.m. CET at the offices of De Brauw Blackstone Westbroek N.V., Burgerweeshuispad 201, 1076 GR Amsterdam, the Netherlands.
May 28, 2024
·
1 min read
1 of 64,645
Next